DKK 225.8
(0.36%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 12.39 Billion DKK | 7.61% |
2022 | 11.58 Billion DKK | 11.07% |
2021 | 10.42 Billion DKK | 13.75% |
2020 | 9.16 Billion DKK | -1.33% |
2019 | 9.29 Billion DKK | 10.8% |
2018 | 8.38 Billion DKK | 8.33% |
2017 | 7.74 Billion DKK | 7.98% |
2016 | 7.16 Billion DKK | 18.2% |
2015 | 6.06 Billion DKK | 18.53% |
2014 | 5.11 Billion DKK | 4.68% |
2013 | 4.88 Billion DKK | 8.96% |
2012 | 4.48 Billion DKK | 10.28% |
2011 | 4.06 Billion DKK | 15.29% |
2010 | 3.52 Billion DKK | 22.3% |
2009 | 2.88 Billion DKK | 15.11% |
2008 | 2.5 Billion DKK | -23.19% |
2007 | 3.26 Billion DKK | 13.3% |
2006 | 2.88 Billion DKK | 12.71% |
2005 | 2.55 Billion DKK | 9.66% |
2004 | 2.33 Billion DKK | 39.89% |
2003 | 1.66 Billion DKK | -1.74% |
2002 | 1.69 Billion DKK | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q1 | 3.15 Billion DKK | -50.44% |
2024 Q2 | 3.15 Billion DKK | 0.0% |
2023 FY | 12.46 Billion DKK | 7.61% |
2023 Q4 | 6.37 Billion DKK | 95.46% |
2023 Q3 | 3.26 Billion DKK | -46.05% |
2023 Q2 | 6.04 Billion DKK | 96.3% |
2023 Q1 | 3.07 Billion DKK | -49.28% |
2022 Q4 | 6.07 Billion DKK | 98.69% |
2022 Q3 | 3.05 Billion DKK | -44.17% |
2022 Q1 | 2.74 Billion DKK | -48.32% |
2022 Q2 | 5.47 Billion DKK | 99.24% |
2022 FY | 11.58 Billion DKK | 11.07% |
2021 Q1 | 2.42 Billion DKK | -47.42% |
2021 Q3 | 2.54 Billion DKK | -49.76% |
2021 Q4 | 5.31 Billion DKK | 109.29% |
2021 Q2 | 5.05 Billion DKK | 108.67% |
2021 FY | 10.42 Billion DKK | 13.75% |
2020 Q1 | 2.07 Billion DKK | -56.33% |
2020 Q2 | 3.99 Billion DKK | 93.14% |
2020 Q3 | 2.31 Billion DKK | -42.09% |
2020 Q4 | 4.6 Billion DKK | 98.96% |
2020 FY | 9.16 Billion DKK | -1.33% |
2019 Q1 | 2.29 Billion DKK | 4.01% |
2019 FY | 9.29 Billion DKK | 10.8% |
2019 Q2 | 4.62 Billion DKK | 101.7% |
2019 Q3 | 2.35 Billion DKK | -49.19% |
2019 Q4 | 4.74 Billion DKK | 101.66% |
2018 Q3 | 2.2 Billion DKK | 10.69% |
2018 Q1 | 1.99 Billion DKK | 1.81% |
2018 Q4 | 2.2 Billion DKK | 0.0% |
2018 FY | 8.38 Billion DKK | 8.33% |
2018 Q2 | 1.99 Billion DKK | 0.0% |
2017 FY | 7.74 Billion DKK | 7.98% |
2017 Q4 | 1.95 Billion DKK | 0.0% |
2017 Q3 | 1.95 Billion DKK | 0.44% |
2017 Q2 | 1.94 Billion DKK | 0.0% |
2017 Q1 | 1.94 Billion DKK | 4.96% |
2016 Q1 | 1.76 Billion DKK | 9.46% |
2016 Q2 | 1.76 Billion DKK | 0.0% |
2016 Q3 | 1.85 Billion DKK | 5.21% |
2016 FY | 7.16 Billion DKK | 18.2% |
2016 Q4 | 1.85 Billion DKK | 0.0% |
2015 FY | 6.06 Billion DKK | 18.53% |
2015 Q4 | 1.61 Billion DKK | 0.0% |
2015 Q3 | 1.61 Billion DKK | 12.61% |
2015 Q2 | 1.43 Billion DKK | 0.0% |
2015 Q1 | 1.43 Billion DKK | 8.78% |
2014 Q4 | 1.31 Billion DKK | 0.0% |
2014 Q3 | 1.31 Billion DKK | 5.87% |
2014 Q1 | 1.24 Billion DKK | -0.6% |
2014 FY | 5.11 Billion DKK | 4.68% |
2014 Q2 | 1.24 Billion DKK | 0.0% |
2013 FY | 4.88 Billion DKK | 8.96% |
2013 Q4 | 1.25 Billion DKK | 0.0% |
2013 Q3 | 1.25 Billion DKK | 6.97% |
2013 Q2 | 1.16 Billion DKK | 0.0% |
2013 Q1 | 1.16 Billion DKK | -0.17% |
2012 Q1 | -1.12 Billion DKK | -10.28% |
2012 Q2 | -1.12 Billion DKK | 0.0% |
2012 FY | 4.48 Billion DKK | 10.28% |
2012 Q3 | 1.17 Billion DKK | 204.41% |
2012 Q4 | 1.17 Billion DKK | 0.0% |
2011 Q1 | -1.01 Billion DKK | -15.29% |
2011 Q4 | -1.01 Billion DKK | 0.0% |
2011 FY | 4.06 Billion DKK | 15.29% |
2011 Q3 | -1.01 Billion DKK | 0.0% |
2011 Q2 | -1.01 Billion DKK | 0.0% |
2010 Q4 | -882.15 Million DKK | 0.0% |
2010 Q2 | -882.15 Million DKK | 0.0% |
2010 Q3 | -882.15 Million DKK | 0.0% |
2010 Q1 | -882.15 Million DKK | -22.3% |
2010 FY | 3.52 Billion DKK | 22.3% |
2009 FY | 2.88 Billion DKK | 15.11% |
2009 Q1 | -721.32 Million DKK | -15.11% |
2009 Q2 | -721.32 Million DKK | 0.0% |
2009 Q3 | -721.32 Million DKK | 0.0% |
2009 Q4 | -721.32 Million DKK | 0.0% |
2008 FY | 2.5 Billion DKK | -23.19% |
2008 Q4 | -626.65 Million DKK | 0.0% |
2008 Q3 | -626.65 Million DKK | 0.0% |
2008 Q2 | -626.65 Million DKK | 0.0% |
2008 Q1 | -626.65 Million DKK | -293.32% |
2007 Q4 | 324.15 Million DKK | 0.0% |
2007 Q3 | 324.15 Million DKK | 0.0% |
2007 FY | 3.26 Billion DKK | 13.3% |
2007 Q2 | 324.15 Million DKK | 0.0% |
2007 Q1 | 324.15 Million DKK | 23.26% |
2006 Q2 | 262.98 Million DKK | 0.0% |
2006 Q3 | 262.98 Million DKK | 0.0% |
2006 Q4 | 262.98 Million DKK | 0.0% |
2006 Q1 | 262.98 Million DKK | 12.93% |
2006 FY | 2.88 Billion DKK | 12.71% |
2005 Q1 | 232.87 Million DKK | 9.79% |
2005 Q4 | 232.87 Million DKK | 0.0% |
2005 FY | 2.55 Billion DKK | 9.66% |
2005 Q3 | 232.87 Million DKK | 0.0% |
2005 Q2 | 232.87 Million DKK | 0.0% |
2004 Q1 | 212.1 Million DKK | 150.09% |
2004 Q2 | 212.1 Million DKK | 0.0% |
2004 FY | 2.33 Billion DKK | 39.89% |
2004 Q3 | 212.1 Million DKK | 0.0% |
2004 Q4 | 212.1 Million DKK | 0.0% |
2003 Q1 | -423.48 Million DKK | 1.85% |
2003 FY | 1.66 Billion DKK | -1.74% |
2003 Q4 | -423.48 Million DKK | 0.0% |
2003 Q3 | -423.48 Million DKK | 0.0% |
2003 Q2 | -423.48 Million DKK | 0.0% |
2002 Q4 | -431.47 Million DKK | 0.0% |
2002 FY | 1.69 Billion DKK | 0.0% |
2002 Q1 | -431.47 Million DKK | 0.0% |
2002 Q2 | -431.47 Million DKK | 0.0% |
2002 Q3 | -431.47 Million DKK | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Ambu A/S | 2.31 Billion DKK | -434.541% |
ChemoMetec A/S | 188.81 Million DKK | -6465.226% |
GN Store Nord A/S | 8.16 Billion DKK | -51.744% |
Scandinavian Medical Solutions A/S | 18.1 Million DKK | -68376.435% |
ViroGates A/S | 18.37 Million DKK | -67379.586% |